Publication Date | SPC No. | SPC Category | Details Rows may repeat to show multiple inventors or applicants depending on "Sort By" |
---|
26 August 2015
(Journal 6588)
| SPC/GB02/019 | Entered Into Force | Applicant: BASF AKTIENGESELLSCHAFT Carl-Bosch-Strasse 38, 67063 Ludwigshafen, Germany
Product: pyraclostrobin
Product Type: Plant Protection Authorised: DE 4951-00 23 October 2001 UK MAPP 10875 21 November 2001
Authorised Extension:
Patent No: EP0804421 Title: Use if 2-(dihydro) pyrazolyl-3'- oxymethylene-anilides as pest-control agents and fungicides
SPC No: SPC/GB02/019 Date entered into force: 21 June 2015 Effective Period Expires On: 22 October 2016 |
26 August 2015
(Journal 6588)
| SPC/GB03/010 | Expired | Applicant: GE Healthcare Limited Amersham Place, Little Chalfont, Buckinghamshire, HP7 9NA
Product: Ioflupane (¹²³I) or [¹²³I]-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-8-(3-fluoropropyl)-nortropane
Product Type: Medicinal Authorised: UK EU/1/00/135/001 2 August 2000
Authorised Extension:
Patent No: EP0703791 Title: AN IODINATED NEUROPROBE FOR MAPPING MONOAMINE REUPTAKE SITES
SPC No: SPC/GB03/010 Date Expired: 1 August 2015 |
26 August 2015
(Journal 6588)
| SPC/GB15/049 | Lodged | Applicant: BASF AGROCHEMICAL PRODUCTS B.V. Groningensingel 1, 6835 EA Arnhem, Netherlands
Product: Mixtures comprising imazamox and quinmerac
Product Type: Plant Protection Authorised: AU 191.047/21-BAES/14 15 May 2014 UK 0272 of 2015 11 February 2015
Authorised Extension:
Patent No: EP1980149 Title: Synergistically acting herbicidal mixtures
SPC No: SPC/GB15/049 Date Lodged: 28 July 2015 |
26 August 2015
(Journal 6588)
| SPC/GB15/050 | Lodged | Applicant: Holostem Terapie Avanzate S.r.L. Via Glauco Gottardi 100, 41100 Modena, Italy
Product: Ex vivo expanded autologous human corneal epithelial cells containing stem cells.
Product Type: Medicinal Authorised: UK EU/1/14/987/0001 19 February 2015
Authorised Extension:
Patent No: EP1451302 Title: In vitro reconstituted sheets of human corneal epithelium and method of producing the same.
SPC No: SPC/GB15/050 Date Lodged: 29 July 2015 |
26 August 2015
(Journal 6588)
| SPC/GB15/051 | Lodged | Applicant: Wyeth Holdings LLC 235 East 42nd Street, New York, New York 10017, USA
Product: Neisseria meningitidis group B fHbp fusion protein and a PorA protein
Product Type: Medicinal Authorised: UK EU/1/12/812 14 January 2013
Authorised Extension:
Patent No: EP2343308 Title: Novel immunogenic compoaitions for the prevention and treatment of meningococcal disease.
SPC No: SPC/GB15/051 Date Lodged: 31 July 2015 |
26 August 2015
(Journal 6588)
| | Expired | Genentech, Inc. 1DNA Way South San Francisco CA 94080-4990 United States of America Product: Etanercept Product Type: Medicinal Authorised: CH 55365 - 1 February 2000 UK EU/1/99/126/001 - 3 February 2000 Authorised Extension: C (2012) 5615 FINAL - 31July 2012 Patent No: EP1029870 Title: Hybrid immunoglobulins for use in therapeutic methods SPC Number SPC/GB08/056 Date Extension Granted: 20 May 2013 (See Journal No 6473 12/06/2013) Extension Expired On: 31 July 2015 |
26 August 2015
(Journal 6588)
| | Expired | Pfizer Ireland Pharmaceuticals Operations Support Group Ringaskiddy Co Cork Ireland Product: Recombinant TNF-R p75 IgG fusion protein lacking the first constant region of the heavy chain of human IgG, such as Etanercept Product Type: Medicinal Authorised: CH SWISS 55365 - 1 February 2000 UK EU/1/99/126/001 - 3 February 2000 UK EU/1/99/126/002 - 3 February 2000 Authorised Extension: EU/1/99/126/001-022 -3 February 2000 Patent No: EP0939121 Title: TNF BINDING PROTEINS SPC Number: SPC/GB03/027 Date Extension Granted: 11 April 2013 (See Journal No 6468 08/05/2013) Extension Expired On: 31 July 2015 |
26 August 2015
(Journal 6588)
| | Expired | Immunex Corporation One Amgen Center Drive Thousand Oaks CA 91320-1799 United States of America Product: Etanercept Product Type: Medicinal Authorised: CH 55365 -1 February 2000 UK EU/1/99/126/001 - 3 February 2000 Authorised Extension: EU/1/99/126/001-022 - 3 February 2000 Patent No: EP0418014 Title: Tumor necrosis factor-alpha and beta receptors SPC Number SPC/GB00/015 Date Extension Granted :12 March 2013 ( See Journal No 6463 03/04/2013) Extension Expired On: 31 July 2015 |